Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies

Data from two phase 3 studies of eribulin were pooled in analyses initially requested by the European Medicines Agency to assess whether specific patient subgroups, previously treated with an anthracycline and a taxane, benefited from eribulin. Study 305/EMBRACE included women after two-to-five line...

Descripción completa

Detalles Bibliográficos
Autores principales: Twelves, Chris, Cortes, Javier, Vahdat, Linda, Olivo, Martin, He, Yi, Kaufman, Peter A., Awada, Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243003/
https://www.ncbi.nlm.nih.gov/pubmed/25381136
http://dx.doi.org/10.1007/s10549-014-3144-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243003/
https://www.ncbi.nlm.nih.gov/pubmed/25381136
http://dx.doi.org/10.1007/s10549-014-3144-y

Ejemplares similares